Shanghai Haohai Biological Technology Co., Ltd. (HKG:6826)

HKG:6826 Revenue

Shanghai Haohai Biological Technology had revenue of 594.68M CNY in the quarter ending September 30, 2025, a decrease of -11.29%. This brings the company's revenue in the last twelve months to 2.50B, down -8.21% year-over-year. In the year 2024, Shanghai Haohai Biological Technology had annual revenue of 2.68B with 1.70% growth.

• Revenue (ttm): 2.50B CNY
• Revenue Growth: -8.21%
• P/S Ratio: 3.95
• Revenue / Employee: 1.16M CNY
• Employees: 2,156
• Market Cap: 10.81B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.68B	44.76M	1.70%
Dec 31, 2023	2.63B	531.47M	25.27%
Dec 31, 2022	2.10B	353.32M	20.19%
Dec 31, 2021	1.75B	425.69M	32.14%
Dec 31, 2020	1.32B	-271.07M	-16.99%